









Markets
/
Stocks
/
nasdaq-qgen
/

Qiagen NV

QGEN

View Detailed Chart

50.570USD

-0.500-0.98%

Close 07/30, 16:00（ET）Quotes delayed by 15 min

10.95BMarket Cap

116.91P/E TTM



Qiagen NV

50.570

-0.500-0.98%

Overview Company Financials

Financials

Intraday

30m

Today

-0.98%

5 Days

+0.34%

1 Month

+5.22%

6 Months

+13.61%

Year to Date

+13.58%

1 Year

+13.12%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 18 analysts

BUY

Current Rating

50.531

Target Price

-1.06%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

553

Total

Median

Average

Company name

Ratings

Analysts

Qiagen NV

QGEN

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(3)

Buy(7)

Indicators

Sell(1)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.282

Buy

RSI(14)

63.539

Neutral

STOCH(KDJ)(9,3,3)

76.104

Neutral

ATR(14)

0.935

High Vlolatility

CCI(14)

58.458

Neutral

Williams %R

29.032

Buy

TRIX(12,20)

0.317

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

51.128

Sell

MA10

50.021

Buy

MA20

49.062

Buy

MA50

47.062

Buy

MA100

43.986

Buy

MA200

43.529

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Ticker SymbolQGEN

CompanyQiagen NV

CEOMr. Thierry Bernard

Websitehttps://www.qiagen.com/